Glycoproteins of Platelet Membranes from Glanzmann's Thrombasthenia. A Comparison with Normal Using Carbohydrate-Specific or Protein-Specific Labelling Techniques and High-Resolution Two-Dimensional Gel Electrophoresis
Open Access
- 30 April 1981
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 116 (2), 379-388
- https://doi.org/10.1111/j.1432-1033.1981.tb05346.x
Abstract
Platelets from Glanzmann's thrombasthenia patients and from normal donors were surface labelled by techniques specific for sugars (terminal sialic acid, penultimate galactose/N-acetylgalactosamine) and proteins (tyrosine-histidine residues). These labelled platelets were solubilized in sodium dodecyl sulphate and separated on a two-dimensional electrophoretic system [O'Farrell, P. H. (1975) J. Biol. Chem. 250, 4007–4021] first according to their isoelectric point (pI) and then according to their molecular weight. In addition, unlabelled sodiumdodecyl-sulphate-solubilized platelets were separated on a two-dimensional polyacrylamide gel and the glycopruteins were identified by binding of 125I-labelled Lens culinaris lectin (specific for mannose and glucose). In one Glanzmann's thrombasthenia patient glycoproteins IIbA1 and IIIaA1 were absent and in two others lower amounts of two glycoproteins were found in positions similar or close to these two membrane glycoproteins. The terminal sialic acid moieties of major glycoproteins (IbA1, IbB1 and IIIbA1) were more intensely labelled in Glanzmann's thrombasthenia than in normals and these glycoproteins had an altered pI. A glycoprotein tentatively designated as Ic/IIa(?) had an altered pI and was labelled more intensely in Glanzmann's thrombasthenia platelets than in normals. A number of low-molecular-weight glycoproteins (IVa, IVb, VII) and one highmolecular weight glycoprotein normally found in platelets of healthy donors were reproducibly not detected in Glanzmann's thrombasthenia platelets. These results obtained by a combination of highly sensitive techniques strongly indicate that in Glanzmann's thrombasthenia the absence or reduction of two major membrane glycoproteins (IIbA1, IIIaA1) is not the only defect but that there appears to be a profound perturbation of the platelet membrane surface.This publication has 22 references indexed in Scilit:
- Studies on Platelet Glycoproteins in Glanzmann's Thrombasthenia using 125I-labelled LectinsBritish Journal of Haematology, 2008
- Identification of ectoproteins of human plateletsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1980
- Characterization of human blood platelet membrane proteins and glycoproteins by their isoelectric point (pI) and apparent molecular weight using two-dimensional electrophoresis and surface-labelling techniquesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1980
- Additional platelet membrane glycoprotein abnormalities in glanzmann's thrombasthenia: A comparison with normals by high resolution two-dimensional polyacrylamide gel electrophoresisThrombosis Research, 1980
- Immunochemical Evidence for Protein Abnormalities in Platelets from Patients with Glanzmann's Thrombasthenia and Bernard-Soulier SyndromeJCI Insight, 1980
- Isolation and immunologic characterization of the human platelet alloantigen, P1A1Molecular Immunology, 1979
- A comparison of techniques used to study externally oriented proteins and glycoproteins of human blood plateletsThrombosis Research, 1979
- Deletion of the Platelet-Specific Alloantigen PlA1 from Platelets in Glanzmann's ThrombastheniaJCI Insight, 1978
- Platelet Membrane Defects in Glanzmann's ThrombastheniaJCI Insight, 1977
- An Abnormal Platelet Glycoprotein Pattern in Three Cases of Glanzmann's ThrombastheniaBritish Journal of Haematology, 1974